Heather B Neuman, MD, MS, FACS

Associate Professor

  • Division of Surgical Oncology

(608) 263-7064

  • Breast Center: (608) 266-6400
  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Box 7375, Clinical Science Center
Madison, WI 53792


  • MD, University of Pittsburgh School of Medicine, Pittsburgh, PA
  • Surgical Oncology Fellow, Memorial Sloan-Kettering Cancer Center, New York, NY
  • Residency in General Surgery, University of North Carolina, Chapel Hill, NC
  • National Research Service Award Fellow, Agency for Healthcare Research and Quality, Weill Medical College of Cornell University, New York, NY
  • Research Fellow in Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
  • MS, Weill Graduate School in Medical Sciences of Cornell University, New York, NY

Clinical Specialties

Dr. Neuman specializes in surgical oncology with a focus on breast, melanoma and sarcoma. She is certified by the American Board of Surgery.

Research Interests

Dr. Neuman’s research focuses on patient-oriented clinical outcomes including patient decision-making, quality of life and survivorship. Her primary research uses mixed methods to improve the quality and efficiency of breast cancer follow-up provided to breast cancer survivors. Secondary research interests include the use of decision aids to improve patient decision-making surrounding breast cancer surgery. Additionally, she is the principal investigator for a number of surgical clinical trials focused on melanoma.

Recent Publications

  • A Four-Arm Randomized Clinical Trial of Topical Pain Control for Sentinel Node Radiotracer Injections in Patients with Breast Cancer.
    Wiener AA, Schumacher JR, Perlman SB, Wilke LG, Lautner MA, Bozzuto LM, Hanlon BM, Neuman HB
    Ann Surg Oncol 2024 Apr 01;
    [PubMed ID: 38557909]

  • Multimodality imaging review of metastatic melanoma involving the breast.
    Brodhead M, Woods RW, Fowler AM, Roy M, Neuman H, Gegios A
    Curr Probl Diagn Radiol 2024; 53(2): 289-296
    [PubMed ID: 38307731]

  • Patient Experience, Adverse Event Reporting, and Clinical Trial Design.
    Neuman HB
    J Clin Oncol 2024 Jan 20; 42(3): 247-249
    [PubMed ID: 38096475]

  • NCCN Guidelines® Insights: Survivorship, Version 1.2023.
    Sanft T, Day A, Ansbaugh S, Armenian S, Baker KS, Ballinger T, Demark-Wahnefried W, Dickinson K, Fairman NP, Felciano J, Flores TF, Friedman DL, Gabel NM, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Koura D, Lee K, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, Neuman H, O'Connor T, Overholser L, Paskett ED, Patel C, Peterson L, Pirl W, Porpiglia A, Rodriguez MA, Schapira L, Schwartz AL, Smith S, Tevaarwerk A, Yang E, Zee P, McMillian NR, Freedman-Cass DA
    J Natl Compr Canc Netw 2023 Aug; 21(8): 792-803
    [PubMed ID: 37549906]

  • Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma.
    Thompson JF, Hyngstrom J, Caracò C, Zager JS, Jahkola T, Bowles TL, Pennacchioli E, Hoekstra HJ, Moncrieff M, Ingvar C, van Akkooi A, Sabel MS, Levine EA, Henderson M, Dummer R, Rossi CR, Kane JM, Trocha S, Wright F, Byrd DR, Matter M, MacKenzie-Ross A, Kelley MC, Terheyden P, Huston TL, Wayne JD, Neuman H, Smithers BM, Desai D, Gershenwald JE, Schneebaum S, Gesierich A, Jacobs LK, Lewis JM, O'Donoghue C, Sardi A, McKinnon JG, Slingluff CL, Farma JM, Schultz E, Scheri RP, Vidal-Sicart S, Testori AAE, Scolyer RA, Elashoff DE, Cochran AJ, Faries MB
    Ann Surg Oncol 2023 Jul; 30(7): 4359-4360
    [PubMed ID: 37149545]

All Publications on PubMed